COST-EFFECTIVENESS AND PUBLIC HEALTH IMPACT OF A NINE-VALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN UKRAINE

被引：0
|
作者：
Ugrekhelidze, D. [1 ]
Pavelyev, A. [2 ]
Daniels, V [3 ]
Grubaia, A. [4 ]
Fedotova, K. [4 ]
机构：
[1] MSD, Zurich, Switzerland
[2] Merck & Co Inc, Rahway, NJ USA
[3] Merck & Co Inc, Rahway, NJ USA
[4] MSD, Kiev, Ukraine
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE596
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [1] Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France
    Majed, Laureen
    Bresse, Xavier
    El Mouaddin, Nadia
    Schmidt, Aurelie
    Daniels, Vincent J.
    Pavelyev, Andrew
    Levy-Bachelot, Laurie
    Elbasha, Elamin
    VACCINE, 2021, 39 (02) : 438 - 446
  • [2] THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF SCHOOL-BASED NINE-VALENT HUMAN PAPILLOMAVIRUS FEMALE VACCINATION COMPARED WITH BI-VALENT AND QUADRIVALENT VACCINATION IN MALAYSIA
    Woo, Y.
    Hsu, T.
    Pavelyev, A.
    LeVan, R.
    Prabhu, V. S.
    VALUE IN HEALTH, 2018, 21 : S7 - S7
  • [3] PUBLIC HEALTH AND ECONOMIC IMPACT OF GENDER- NEUTRAL NINE-VALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN ALGERIA
    Khatri, D.
    Daniels, V
    Pavelyev, A.
    Bennacef, Ac
    Boufassa, K.
    Ugrekhelidze, D.
    VALUE IN HEALTH, 2024, 27 (12)
  • [4] COST-EFFECTIVENESS OF GENDER-NEUTRAL NINE-VALENT HPV VACCINATION IN DENMARK
    Olsen, J.
    le Fevre, T.
    Blaakaer, J.
    VALUE IN HEALTH, 2018, 21 : S229 - S229
  • [5] EPIDEMIOLOGICAL AND ECONOMIC IMPACT OF GENDER-NEUTRAL NINE-VALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN KAZAKHSTAN
    Kaidarova, D.
    Ugrekhelidze, D.
    Daniels, V
    Pavelyev, A.
    Mamane, C.
    VALUE IN HEALTH, 2024, 27 (12) : S96 - S97
  • [6] ESTIMATING THE COST-EFFECTIVENESS PROFILE OF A VACCINATION PROGRAMME WITH A NINE-VALENT HPV VACCINE IN ITALY
    Mennini, F. S.
    Bianic, F.
    Baio, G.
    Largeron, N.
    Plazzotta, G.
    Rinaldi, A.
    De Waure, C.
    Bonanni, P.
    VALUE IN HEALTH, 2015, 18 (07) : A457 - A457
  • [7] Nine-Valent Human Papillomavirus Vaccine Recommended for Routine Vaccination
    不详
    CLINICAL INFECTIOUS DISEASES, 2015, 60 (11) : I - II
  • [8] The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
    Ke Zhu
    Yuke Tian
    Xiaomei Dong
    Babatunde O. Akinwunmi
    Casper J. P. Zhang
    Jian Huang
    Wai-kit Ming
    Archives of Gynecology and Obstetrics, 2022, 306 : 173 - 187
  • [9] The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
    Zhu, Ke
    Tian, Yuke
    Dong, Xiaomei
    Akinwunmi, Babatunde O.
    Zhang, Casper J. P.
    Huang, Jian
    Ming, Wai-kit
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (01) : 173 - 187
  • [10] Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
    Mennini, Francesco Saverio
    Bonanni, Paolo
    Bianic, Florence
    de Waure, Chiara
    Baio, Gianluca
    Plazzotta, Giacomo
    Uhart, Mathieu
    Rinaldi, Alessandro
    Largeron, Nathalie
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2017, 15
12345